Reoperation for recurrent high-grade glioma: A current perspective of the literature

Neurosurgery

Volumn 75, Issue 5, 2014, Pages 491-498

  Hervey Jumper, Shawn L ^a   Berger, Mitchel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extent of resection; High grade glioma; Reoperation; Salvage therapy

Indexed keywords

BEVACIZUMAB; TEMOZOLOMIDE;

AGE DISTRIBUTION; ANTIANGIOGENIC ACTIVITY; BRACHYTHERAPY; CANCER GENE THERAPY; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CRANIOTOMY; DATA BASE; DEPRESSION; FUNCTIONAL STATUS; GLIOMA; HEADACHE; HISTOPATHOLOGY; HUMAN; INFECTION; INTRACRANIAL PRESSURE; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; MEDLINE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION NECROSIS; REOPERATION; REVIEW; SEIZURE; SURVIVAL TIME; TUMOR GROWTH; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION; WOUND HEALING; ADULT; AGED; BRAIN NEOPLASMS; MALE; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; BRAIN NEOPLASMS; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; REOPERATION; RETROSPECTIVE STUDIES;

EID: 84924376838     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000486     Document Type: Review

References (39)

1. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114-123
2. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus. 2006;20(4):E1
3. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol. 1998;40(2):151-160
4. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20(5): 1375-1382
5. Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012;117 (6):1032-1038
6. Chaichana KL, Zadnik P, Weingart JD, et al. Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg. 2013;118(4):812-820
7. Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98(6):1175-1181
8. Harsh GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery. 1987;21(5): 615-621
9. Helseth R, Helseth E, Johannesen TB, et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand. 2010;122(3):159-167
10. Rusthoven KE, Olsen C, Franklin W, et al. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. Int J Radiat Oncol Biol Phys. 2011;81(1):211-217
11. Terasaki M, Ogo E, Fukushima S, et al. Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. Surg Neurol. 2007;68(3):250-254
12. Young B, Oldfield EH, Markesbery WR, et al. Reoperation for glioblastoma. J Neurosurg. 1981;55(6):917-921
13. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987;21(5):607-614
14. Azizi A, Black P, Miyamoto C, Croul SE. Treatment of malignant astrocytomas with repetitive resections: a longitudinal study. Isr Med Assoc J. 2001;3(4):254-257
15. Barker FG II, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998;42(4):709-720
16. Clark AJ, Butowski NA, Chang SM, et al. Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg. 2011;114(6):1609-1616
17. Clark AJ, Lamborn KR, Butowski NA, et al. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery. 2012;70(2):361-370
18. Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg. 1993;36(3):271-275
19. Durmaz R, Erken S, Arslantas A, Atasoy MA, Bal C, Tel E. Management of glioblastoma multiforme: with special reference to recurrence. Clin Neurol Neurosurg. 1997;99(2):117-123
20. Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg. 2004; 100(1):41-46
21. Landy HJ, Feun L, Schwade JG, Snodgrass S, Lu Y, Gutman F. Retreatment of intracranial gliomas. South Med J. 1994;87(2):211-214
22. Mandl ES, Dirven CM, Buis DR, Postma TJ, Vandertop WP. Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol. 2008;69(5):506-509
23. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1):156-162
24. Park JK, Hodges T, Arko L, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28(24):3838-3843
25. Pinsker M, Lumenta C. Experiences with reoperation on recurrent glioblastoma multiforme. Zentralbl Neurochir. 2001;62(2):43-47
26. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery. 1994;35(3):378-388
27. Salcman M, Kaplan RS, Ducker TB, Abdo H, Montgomery E. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery. 1982;10(4):454-463
28. Sipos L, Afra D. Re-operations of supratentorial anaplastic astrocytomas. Acta Neurochir (Wien). 1997;139(2):99-104
29. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM. Glioblastoma: the consequences of advanced patient age on treatment and survival. Neurosurg Rev. 2007;30(1):56-61
30. Tugcu B, Postalci LS, Gunaldi O, Tanriverdi O, Akdemir H. Efficacy of clinical prognostic factors on survival in patients with glioblastoma. Turk Neurosurg. 2010; 20(2):117-125
31. Vick NA, Ciric IS, Eller TW, Cozzens JW, Walsh A. Reoperation for malignant astrocytoma. Neurology. 1989;39(3):430-432
32. Wallner KE, Galicich JH, Malkin MG, Arbit E, Krol G, Rosenblum MK. Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J Clin Oncol. 1989;7(10):1492-1496
33. Woodworth GF, Garzon-Muvdi T, Ye X, Blakeley JO, Weingart JD, Burger PC. Histopathological correlates with survival in reoperated glioblastomas. J Neurooncol. 2013;113(3):485-493
34. Brada M, Hoang-Xuan K, Rampling R, et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol. 2001;12(2):259-266
35. Skeie BS, Enger PO, BrOgger J, et al. Gamma Knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg. 2012;78(6):658-669
36. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198
37. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115 (1):3-8
38. Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009; 27(28):4733-4740
39. Strömblad LG, Anderson H, Malmström P, Salford LG. Reoperation for malignant astrocytomas: personal experience and a review of the literature. Br J Neurosurg. 1993;7(6):623-633